ANRO
Alto Neuroscience, Inc.
NYSE · Healthcare · Biotechnology · US
$35.55
−2.34%Aug 27, 2026, 20:05 UTC
Alto Neuroscience promoted Nick Smith to president and chief financial officer, effective August 26, 2026.
Source:Aug 25, 2026, 07:47 UTC
Alto Neuroscience, Inc. (NYSE: ANRO) shares reached a new 52-week high of $36.99 during mid-day trading on Tuesday, with the last trade at $36.4220 and volume of 867,909 shares, after closing at $34.28 the previous day.
Source:Jul 13, 2026, 11:47 UTC
Alto Neuroscience priced an underwritten registered direct offering of 3,776,436 shares of common stock at $26.48 per share, expecting gross proceeds of $100.0 million.
Source: